Asia Pacific Deep Brain Simulation Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson's Disease, Tremor, Dystonia, Epilepsy, Alzheimer's Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)


No. of Pages: 91    |    Report Code: BMIRE00029018    |    Category: Life Sciences

Asia Pacific Deep Brain Simulation Market
Buy Now

The Asia Pacific deep brain simulation market is expected to grow from US$ 98.35 million in 2022 to US$ 188.04 million by 2030. It is estimated to grow at a CAGR of 8.4% from 2022 to 2030.

Technological Advancements and Approvals in Deep Brain Stimulation Drive Asia Pacific Deep Brain Simulation Market 

Robotic implantation, multi-target stimulation, improved microelectrode designs, rechargeable pulse generators, and personalized, targeted programming are among the technological advancements in deep brain stimulation (DBS). Owing to these advancements, DBS devices show fewer side effects and improved efficacy and symptom relief in Parkinson's patients compared to traditional methods. Abbott's Infinity Deep Brain Stimulation System is a technologically advanced new DBS that helps the patients manage their symptoms. It is the first wireless iOS software DBS mobile platform that has offered efficient and personalized therapy management with reduced risk of side effects. According to the MGM Healthcare press release published in February 2020, MGM Healthcare, Tamil Nadu, performed its first deep brain stimulation (DBS) for obsessive-compulsive disorder (OCD). Therefore, technological advancements in DBS are expected to create opportunities for the Asia Pacific deep brain stimulation market during the forecast period.

Asia Pacific Deep Brain Simulation Market Overview

China is home to the world's largest population of older adults. According to a study published in The Lancet titled “China's Aging Population: Crisis or Opportunity?” in 2019, people in China aged 60 or older were ~254 million. By 2040, that number is expected to rise to 402 million, ~28% of the population. These changes have profound public health implications in the country as the risk and burden of noncommunicable diseases increase along with the demand for health and social care systems. Parkinson's disease (PD) is a common neurodegenerative disease in the country. According to ChinaDaily, there were approximately 4 million Parkinson's patients in China as of February 2023, and ~1.7% of people over 65 years have been diagnosed with the disease. According to a study discussed in the Journal of Health, Population, and Nutrition, the number of people with Alzheimer's disease in China is ~6 million, with dementia rates among 65-, 75-, and 85-year-olds being 5%, 11.5%, and 30%, respectively. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is effective in the treatment of Parkinson's disease (PD). With advancements in DBS hardware, researchers have developed several novel programming technologies, of which remote programming is widely used in China. Since 2018, we have been performing remote programming for patients suffering from PD using PINS products (PINS Medical, Ltd., Beijing, China). For patients with advanced Parkinson's disease (over a 15-year time horizon), DBS is considered to be a highly effective treatment option. However, DBS remains a significant economic burden on the patient when not reimbursed, unlike in any other developed country. In China, the surgery cost is mainly covered by the patient's health insurance, but the cost of DBS hardware is only partially covered, which can hamper the growth of the market in the country.

Asia Pacific Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Million)
Get more information on this report

Asia Pacific Deep Brain Simulation Strategic Insights

Strategic insights for the Asia Pacific Deep Brain Simulation provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/asia-pacific-deep-brain-simulation-market-strategic-framework.webp
Get more information on this report

Asia Pacific Deep Brain Simulation Report Scope

Report Attribute Details
Market size in 2022 US$ 98.35 Million
Market Size by 2030 US$ 188.04 Million
Global CAGR (2022 - 2030) 8.4%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Product
  • Single Channel Deep Brain Stimulator
  • Dual Channel Deep Brain Stimulator
  • Software and Accessories
By Application
  • Parkinson's Disease
  • Tremor
  • Dystonia
  • Epilepsy
  • Alzheimer's Disease
By End User
  • Hospitals
  • Neurology Clinics
  • Ambulatory Surgical Centers
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Abbott Laboratories
  • Beijing PINS Medical Co Ltd
  • Boston Scientific Corp
  • Medtronic Plc
  • SceneRay Co Ltd
  • Get more information on this report

    Asia Pacific Deep Brain Simulation Regional Insights

    The geographic scope of the Asia Pacific Deep Brain Simulation refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/asia-pacific-deep-brain-simulation-market-geography.webp
    Get more information on this report

    Asia Pacific Deep Brain Simulation Market Segmentation

    The Asia Pacific deep brain simulation market is segmented into product, application, end user, and country.

    Based on product, the Asia Pacific deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. In 2022, the dual channel deep brain stimulator segment registered the largest share in the Asia Pacific deep brain simulation market.

    Based on application, the Asia Pacific deep brain simulation market is segmented into Parkinson’s disease, tremor, dystonia, epilepsy, Alzheimer’s disease, and others. In 2022, the Parkinson’s disease segment registered the largest share in the Asia Pacific deep brain simulation market.

    Based on end user, the Asia Pacific deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the largest share in the Asia Pacific deep brain simulation market.

    Based on country, the Asia Pacific deep brain simulation market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. In 2022, China segment registered the largest share in the Asia Pacific deep brain simulation market.

    Abbott Laboratories, Beijing PINS Medical Co Ltd, Boston Scientific Corp, Medtronic Plc, and SceneRay Co Ltd are some of the leading companies operating in the Asia Pacific deep brain simulation market.   

    The List of Companies - Asia Pacific Deep Brain Simulation Market

    1. Abbott Laboratories               
    2. Beijing PINS Medical Co Ltd            
    3. Boston Scientific Corp                  
    4. Medtronic Plc                                 
    5. SceneRay Co Ltd                            
    Frequently Asked Questions
    How big is the Asia Pacific Deep Brain Simulation Market?

    The Asia Pacific Deep Brain Simulation Market is valued at US$ 98.35 Million in 2022, it is projected to reach US$ 188.04 Million by 2030.

    What is the CAGR for Asia Pacific Deep Brain Simulation Market by (2022 - 2030)?

    As per our report Asia Pacific Deep Brain Simulation Market, the market size is valued at US$ 98.35 Million in 2022, projecting it to reach US$ 188.04 Million by 2030. This translates to a CAGR of approximately 8.4% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Deep Brain Simulation Market report typically cover these key segments-

    • Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, Software and Accessories)
    • Application (Parkinson's Disease, Tremor, Dystonia, Epilepsy, Alzheimer's Disease)
    • End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers)

    What is the historic period, base year, and forecast period taken for Asia Pacific Deep Brain Simulation Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Deep Brain Simulation Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Asia Pacific Deep Brain Simulation Market?

    The Asia Pacific Deep Brain Simulation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott Laboratories
  • Beijing PINS Medical Co Ltd
  • Boston Scientific Corp
  • Medtronic Plc
  • SceneRay Co Ltd
  • Who should buy this report?

    The Asia Pacific Deep Brain Simulation Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Deep Brain Simulation Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now